-
SBI Healthcare Opportunities IDCW-R
Equity healthcare
Overview ( as on 10/12/25 )
NAV
₹265.97
Last change
₹1.43 +0.01%
Fund Size (AUM)
4130.76 Cr
Performance
17.08% (5Y)
Fund Details
SBI Healthcare Opportunities IDCW-R
as of 10/12/25
AUM
4130.76 Cr
Expense Ratio
1.93 %
Benchmark
BSE Healthcare TR INR
ISIN
INF200K01461
Fund Manager
Tanmaya Desai
Exit Load
0.5% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| SBI Healthcare Opportunities IDCW-R | -2.04% | 23.26% | 17.08% |
| BSE Healthcare TR INR | 2.79% | 23.3% | 17.18% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.97% |
Divi's Laboratories Ltd |
6.9% |
Max Healthcare Institute Ltd Ordinary Shares |
5.63% |
Cipla Ltd |
4.45% |
Lupin Ltd |
4.23% |
Acutaas Chemicals Ltd |
4.0% |
Torrent Pharmaceuticals Ltd |
3.6% |
Laurus Labs Ltd |
3.5% |
Fortis Healthcare Ltd |
3.34% |
Aster DM Healthcare Ltd Ordinary Shares |
3.25% |
Sector Allocation
Healthcare |
92.72% |
Basic Materials |
7.28% |
Asset Allocation
-
96%
Equity
-
4%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
15.58% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
15.58% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
15.58% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
17.08% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R
Equity healthcare-
Returns
-
17.08% (5Y)
-
-
Tata India Pharma & Healthcare Growth
Equity healthcare-
Returns
-
15.72% (5Y)
-
